サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1717269

患者リスク層別化の世界市場レポート 2025年

Patient Risk Stratification Global Market Report 2025

出版日
ページ情報
英文 175 Pages
納期
2～10営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.91円
患者リスク層別化の世界市場レポート 2025年
出版日: 2025年04月29日
発行: The Business Research Company
ページ情報: 英文 175 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

患者リスク層別化市場規模は、今後数年で飛躍的な成長が見込まれます。2029年には年間平均成長率（CAGR）31.0％で83億米ドルに成長します。今後、予測期間中の成長は、中間層と医療保険の適用範囲の拡大、慢性疾患の有病率の増加、予測分析の採用の高まり、健康の社会的決定要因（SDOH）への注目の高まり、テクノロジーの広範な利用によって牽引されると予想されます。予測期間における主な動向には、アナリティクス、人工知能（AI）、機械学習、ヘルスケア技術革新、ウェアラブル技術、遠隔モニタリングの進歩が含まれます。

慢性疾患の負担増が患者リスク層別化市場の成長を牽引すると予測されます。慢性疾患は、通常3カ月以上続く長期的な健康状態です。慢性疾患の増加は、高齢化、不健康なライフスタイル、都市化、環境要因、ヘルスケアへのアクセス制限、経済格差、ストレスレベルの上昇など、いくつかの要因に起因しています。患者リスク層別化は、慢性疾患の様々なリスクレベルにある個人を特定し、個別化ケア、早期介入、より良いリソース管理、健康アウトカムの改善を可能にします。例えば、2023年1月、米国立生物工学情報センター（NCBI）は、少なくとも1つの慢性疾患を持つ50歳以上の個人の数が、2020年の7,150万人から2050年には1億4,270万人へと99.5％増加すると予測しました。さらに、世界保健機関（WHO）は2022年9月、慢性疾患が世界全体の死因の74％を占め、年間4,100万人が死亡していることを明らかにしました。心血管疾患が1,790万人、がんが930万人、慢性呼吸器疾患が410万人、糖尿病が200万人の死因となっています。その結果、慢性疾患の有病率の上昇が患者リスク層別化市場の主要な促進要因となっています。

患者リスク層別化市場の企業は、より正確なリスク評価と個別化された治療計画を提供することで、早期発見や患者の転帰を改善し、医療費を削減するために、疾患スクリーニングにおける人工知能（AI）などのヘルスケア技術を推進しています。疾患スクリーニングにおけるAIは、医療データの分析に高度なアルゴリズムと機械学習を採用し、大規模なデータセットを迅速に処理することで疾患の早期発見を容易にし、診断精度を向上させる。例えば、2024年5月、カナダのヘルスケア企業であるWELL Health Technologies Corporationは、その投資先企業であるHEALWELL AIとともに、WELL AI Decision Support（WAIDS）を立ち上げました。このツールは、希少疾患や腎臓病、高血圧、糖尿病などの慢性疾患に焦点を当て、リスク層別化を提供し、臨床医がケアの時点でケアギャップや実用的なデータを特定するのを支援します。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- マクロ経済シナリオ金利、インフレ、地政学、新型コロナウイルス感染症の影響と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

  • 世界の患者リスク層別化PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
  • 最終用途産業の分析
  • 世界の患者リスク層別化市場：成長率分析
  • 世界の患者リスク層別化市場の実績：規模と成長、2019年～2024年
  • 世界の患者リスク層別化市場の予測：規模と成長、2024年～2029年、2034年
  • 世界の患者リスク層別化総アドレス可能市場（TAM）

第6章 市場セグメンテーション

  • 世界の患者リスク層別化市場：タイプ別、実績と予測、2019年～2024年、2024年～2029年、2034年
  • 予測リスク層別モデル
  • 遡及的リスク層別モデル
  • 将来的リスク層別モデル
  • 同時リスク層別モデル
  • 世界の患者リスク層別化市場：コンポーネント別、実績と予測、2019年～2024年、2024年～2029年、2034年
  • ソフトウェア
  • サービス
  • 世界の患者リスク層別化市場：配信モデル別、実績と予測、2019年～2024年、2024年～2029年、2034年
  • オンプレミス
  • クラウドベース
  • 世界の患者リスク層別化市場：用途別、実績と予測、2019年～2024年、2024年～2029年、2034年
  • リスク調整
  • 臨床ワークフロー
  • 収益サイクル管理
  • その他の用途
  • 世界の患者リスク層別化市場：エンドユーザー別、実績と予測、2019年～2024年、2024年～2029年、2034年
  • ヘルスケア提供者
  • ヘルスケア支払者
  • その他のエンドユーザー
  • 世界の患者リスク層別化市場、予測リスク層別モデルのサブセグメンテーション（タイプ別）、実績と予測、2019年～2024年、2024年～2029年、2034年
  • 機械学習ベースの予測モデル
  • 統計予測モデル
  • AIを活用した予測モデル
  • 世界の患者リスク層別化市場、遡及的リスク層別モデルのサブセグメンテーション（タイプ別）、実績と予測、2019年～2024年、2024年～2029年、2034年
  • 履歴データに基づくリスクモデル
  • データマイニングの回顧的モデル
  • 世界の患者リスク層別化市場、タイプ別リスク層別化モデルのサブセグメンテーション、実績と予測、2019年～2024年、2024年～2029年、2034年
  • 縦断的コホートベースモデル
  • リアルタイムリスク評価モデル
  • 世界の患者リスク層別化市場、同時リスク層別モデルのサブセグメンテーション（タイプ別）、実績と予測、2019年～2024年、2024年～2029年、2034年
  • 院内リスク評価モデル
  • リアルタイム臨床意思決定支援モデル

第7章 地域別・国別分析

  • 世界の患者リスク層別化市場：地域別、実績と予測、2019年～2024年、2024年～2029年、2034年
  • 世界の患者リスク層別化市場：国別、実績と予測、2019年～2024年、2024年～2029年、2034年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • 患者リスク層別化市場：競合情勢
  • 患者リスク層別化市場：企業プロファイル
    • Bristol-Myers Squibb Overview, Products and Services, Strategy and Financial Analysis
    • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • Sales Force Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Medtronic plc Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

  • Siemens Healthineers AG
  • Koninklijke Philips N.V.
  • GE HealthCare Technologies Inc.
  • Adobe Inc.
  • Persistent Systems
  • NextGen Healthcare Inc.
  • Health Catalyst
  • Freenome
  • Strive Health
  • Medeanalytics Inc.
  • American Academy of Family Physicians
  • Lightbeam Health Solutions
  • Graphnet Health Ltd.
  • Innova Medical Group Inc.
  • Equipo Health Inc.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

  • 患者リスク層別化市場2029年：新たな機会を提供する国
  • 患者リスク層別化市場2029年：新たな機会を提供するセグメント
  • 患者リスク層別化市場2029年：成長戦略
    • 市場動向に基づく戦略
    • 競合の戦略

第36章 付録

目次
Product Code: r33847

Patient risk stratification involves evaluating and classifying patients based on their likelihood of experiencing adverse health events. This process helps identify high-risk individuals for targeted interventions, optimize the use of resources, promote preventive care, improve care coordination, enhance patient outcomes, reduce costs, and aid in managing population health.

The primary types of patient risk stratification include predictive, retrospective, prospective, and concurrent models. Predictive risk stratification models analyze historical and current patient data to predict future health outcomes and identify those at high risk of developing particular conditions or complications. These models consist of software and services, with delivery options available both on-premise and via the cloud. Key applications include risk adjustment, clinical workflows, revenue cycle management, among others, and they are utilized by various end users, including healthcare providers, payers, and others.

The patient risk stratification market research report is one of a series of new reports from The Business Research Company that provides patient risk stratification market statistics, including patient risk stratification industry global market size, regional shares, competitors with a patient risk stratification market share, detailed patient risk stratification market segments, market trends and opportunities, and any further data you may need to thrive in the patient risk stratification industry. This patient risk stratification market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The patient risk stratification market size has grown exponentially in recent years. It will grow from $2.15 billion in 2024 to $2.82 billion in 2025 at a compound annual growth rate (CAGR) of 31.3%. The growth during the historical period can be attributed to the growing adoption of digitization, increased health risks, an aging population, a rise in medical errors, and the widespread use of electronic health records (EHR).

The patient risk stratification market size is expected to see exponential growth in the next few years. It will grow to $8.30 billion in 2029 at a compound annual growth rate (CAGR) of 31.0%. Looking ahead, growth during the forecast period is expected to be driven by the expanding middle class and health insurance coverage, the increasing prevalence of chronic diseases, the rising adoption of predictive analytics, a greater focus on social determinants of health (SDOH), and the broader use of technology. Key trends in the forecast period include advancements in analytics, artificial intelligence (AI), machine learning, healthcare technological innovations, wearable technology, and remote monitoring.

The increasing burden of chronic diseases is expected to drive the growth of the patient risk stratification market. Chronic diseases are long-term health conditions that typically last for three months or longer. The rise in chronic diseases can be attributed to several factors, including an aging population, unhealthy lifestyles, urbanization, environmental factors, limited access to healthcare, economic disparities, and elevated stress levels. Patient risk stratification helps identify individuals at varying risk levels for chronic diseases, enabling personalized care, early intervention, better resource management, and improved health outcomes. For example, in January 2023, the National Center for Biotechnology Information (NCBI) projected that the number of individuals aged 50 and older with at least one chronic illness will increase by 99.5%, from 71.5 million in 2020 to 142.7 million by 2050. Additionally, the World Health Organization (WHO) highlighted in September 2022 that chronic diseases are responsible for 74% of all deaths globally, equating to 41 million deaths annually. Cardiovascular diseases account for 17.9 million deaths, cancer causes 9.3 million, chronic respiratory diseases lead to 4.1 million deaths, and diabetes results in 2 million deaths. Consequently, the rising prevalence of chronic diseases is a major driver of the patient risk stratification market.

Companies in the patient risk stratification market are advancing healthcare technologies, such as artificial intelligence (AI) in disease screening, to improve early detection, patient outcomes, and reduce healthcare costs by providing more accurate risk assessments and personalized treatment plans. AI in disease screening employs sophisticated algorithms and machine learning to analyze medical data, facilitating early disease detection and improving diagnostic accuracy by quickly processing large datasets. For example, in May 2024, WELL Health Technologies Corporation, a Canadian healthcare company, alongside its investee company HEALWELL AI, launched WELL AI Decision Support (WAIDS). This tool focuses on rare diseases and chronic conditions such as kidney disease, hypertension, and diabetes, offering risk stratification and helping clinicians identify care gaps and actionable data at the point of care.

In December 2023, Healthcare Outcomes Performance Company (HOPCo), a US-based provider specializing in healthcare performance improvement solutions, acquired MyACTome, a US-based company that offers a smartphone platform for assessing fall risk and frailty. This acquisition is aimed at improving patient outcomes and enhancing healthcare efficiency, particularly in patient risk stratification.

Major players in the patient risk stratification market are Bristol-Myers Squibb, Thermo Fisher Scientific Inc., Abbott Laboratories, Sales Force Inc., Medtronic plc, Siemens Healthineers AG, Koninklijke Philips N.V., GE HealthCare Technologies Inc., Adobe Inc., Persistent Systems, NextGen Healthcare Inc., Health Catalyst, Freenome, Strive Health, Medeanalytics Inc., American Academy of Family Physicians, Lightbeam Health Solutions, Graphnet Health Ltd., Innova Medical Group Inc., Equipo Health Inc., Epic Systems Corporation

North America was the largest region in the patient risk stratification market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in patient risk stratification report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the patient risk stratification market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The patient risk stratification market includes revenues earned by entities by risk assessment and stratification services, telehealth services, medication management services, chronic disease risk assessment services, and genomic risk stratification services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Patient Risk Stratification Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on patient risk stratification market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for patient risk stratification ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The patient risk stratification market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Predictive Risk Stratification Model; Retrospective Risk Stratification Model; Prospective Risk Stratification Model; Concurrent Risk Stratification Model
  • 2) By Component: Software; Services
  • 3) By Delivery Model: On-Premise; Cloud-Based
  • 4) By Application: Risk Adjustment; Clinical Workflow; Revenue Cycle Management; Other Applications
  • 5) By End User: Healthcare Providers; Healthcare Payers; Other End Users
  • Subsegments:
  • 1) By Predictive Risk Stratification Model: Machine Learning-Based Predictive Models; Statistical Predictive Models; AI-Powered Predictive Models
  • 2) By Retrospective Risk Stratification Model: Historical Data-Based Risk Models; Data Mining Retrospective Models
  • 3) By Prospective Risk Stratification Model: Longitudinal Cohort-Based Models; Real-Time Risk Assessment Models
  • 4) By Concurrent Risk Stratification Model: In-Hospital Risk Assessment Models; Real-Time Clinical Decision Support Models
  • Companies Mentioned: Bristol-Myers Squibb; Thermo Fisher Scientific Inc.; Abbott Laboratories; Sales Force Inc.; Medtronic plc
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Patient Risk Stratification Market Characteristics

3. Patient Risk Stratification Market Trends And Strategies

4. Patient Risk Stratification Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Patient Risk Stratification Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Patient Risk Stratification PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Patient Risk Stratification Market Growth Rate Analysis
  • 5.4. Global Patient Risk Stratification Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Patient Risk Stratification Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Patient Risk Stratification Total Addressable Market (TAM)

6. Patient Risk Stratification Market Segmentation

  • 6.1. Global Patient Risk Stratification Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Predictive Risk Stratification Model
  • Retrospective Risk Stratification Model
  • Prospective Risk Stratification Model
  • Concurrent Risk Stratification Model
  • 6.2. Global Patient Risk Stratification Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Software
  • Services
  • 6.3. Global Patient Risk Stratification Market, Segmentation By Delivery Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • On-Premise
  • Cloud-Based
  • 6.4. Global Patient Risk Stratification Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Risk Adjustment
  • Clinical Workflow
  • Revenue Cycle Management
  • Other Applications
  • 6.5. Global Patient Risk Stratification Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Healthcare Providers
  • Healthcare Payers
  • Other End Users
  • 6.6. Global Patient Risk Stratification Market, Sub-Segmentation Of Predictive Risk Stratification Model, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Machine Learning-Based Predictive Models
  • Statistical Predictive Models
  • AI-Powered Predictive Models
  • 6.7. Global Patient Risk Stratification Market, Sub-Segmentation Of Retrospective Risk Stratification Model, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Historical Data-Based Risk Models
  • Data Mining Retrospective Models
  • 6.8. Global Patient Risk Stratification Market, Sub-Segmentation Of Prospective Risk Stratification Model, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Longitudinal Cohort-Based Models
  • Real-Time Risk Assessment Models
  • 6.9. Global Patient Risk Stratification Market, Sub-Segmentation Of Concurrent Risk Stratification Model, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • In-Hospital Risk Assessment Models
  • Real-Time Clinical Decision Support Models

7. Patient Risk Stratification Market Regional And Country Analysis

  • 7.1. Global Patient Risk Stratification Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Patient Risk Stratification Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Patient Risk Stratification Market

  • 8.1. Asia-Pacific Patient Risk Stratification Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Patient Risk Stratification Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Patient Risk Stratification Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Patient Risk Stratification Market, Segmentation By Delivery Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Patient Risk Stratification Market

  • 9.1. China Patient Risk Stratification Market Overview
  • 9.2. China Patient Risk Stratification Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Patient Risk Stratification Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Patient Risk Stratification Market, Segmentation By Delivery Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Patient Risk Stratification Market

  • 10.1. India Patient Risk Stratification Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Patient Risk Stratification Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Patient Risk Stratification Market, Segmentation By Delivery Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Patient Risk Stratification Market

  • 11.1. Japan Patient Risk Stratification Market Overview
  • 11.2. Japan Patient Risk Stratification Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Patient Risk Stratification Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Patient Risk Stratification Market, Segmentation By Delivery Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Patient Risk Stratification Market

  • 12.1. Australia Patient Risk Stratification Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Patient Risk Stratification Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Patient Risk Stratification Market, Segmentation By Delivery Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Patient Risk Stratification Market

  • 13.1. Indonesia Patient Risk Stratification Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Patient Risk Stratification Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Patient Risk Stratification Market, Segmentation By Delivery Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Patient Risk Stratification Market

  • 14.1. South Korea Patient Risk Stratification Market Overview
  • 14.2. South Korea Patient Risk Stratification Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Patient Risk Stratification Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Patient Risk Stratification Market, Segmentation By Delivery Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Patient Risk Stratification Market

  • 15.1. Western Europe Patient Risk Stratification Market Overview
  • 15.2. Western Europe Patient Risk Stratification Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Patient Risk Stratification Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Patient Risk Stratification Market, Segmentation By Delivery Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Patient Risk Stratification Market

  • 16.1. UK Patient Risk Stratification Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Patient Risk Stratification Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Patient Risk Stratification Market, Segmentation By Delivery Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Patient Risk Stratification Market

  • 17.1. Germany Patient Risk Stratification Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Patient Risk Stratification Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Patient Risk Stratification Market, Segmentation By Delivery Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Patient Risk Stratification Market

  • 18.1. France Patient Risk Stratification Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Patient Risk Stratification Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Patient Risk Stratification Market, Segmentation By Delivery Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Patient Risk Stratification Market

  • 19.1. Italy Patient Risk Stratification Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Patient Risk Stratification Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Patient Risk Stratification Market, Segmentation By Delivery Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Patient Risk Stratification Market

  • 20.1. Spain Patient Risk Stratification Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Patient Risk Stratification Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Patient Risk Stratification Market, Segmentation By Delivery Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Patient Risk Stratification Market

  • 21.1. Eastern Europe Patient Risk Stratification Market Overview
  • 21.2. Eastern Europe Patient Risk Stratification Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Patient Risk Stratification Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Patient Risk Stratification Market, Segmentation By Delivery Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Patient Risk Stratification Market

  • 22.1. Russia Patient Risk Stratification Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Patient Risk Stratification Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Patient Risk Stratification Market, Segmentation By Delivery Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Patient Risk Stratification Market

  • 23.1. North America Patient Risk Stratification Market Overview
  • 23.2. North America Patient Risk Stratification Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Patient Risk Stratification Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Patient Risk Stratification Market, Segmentation By Delivery Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Patient Risk Stratification Market

  • 24.1. USA Patient Risk Stratification Market Overview
  • 24.2. USA Patient Risk Stratification Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Patient Risk Stratification Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Patient Risk Stratification Market, Segmentation By Delivery Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Patient Risk Stratification Market

  • 25.1. Canada Patient Risk Stratification Market Overview
  • 25.2. Canada Patient Risk Stratification Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Patient Risk Stratification Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Patient Risk Stratification Market, Segmentation By Delivery Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Patient Risk Stratification Market

  • 26.1. South America Patient Risk Stratification Market Overview
  • 26.2. South America Patient Risk Stratification Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Patient Risk Stratification Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Patient Risk Stratification Market, Segmentation By Delivery Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Patient Risk Stratification Market

  • 27.1. Brazil Patient Risk Stratification Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Patient Risk Stratification Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Patient Risk Stratification Market, Segmentation By Delivery Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Patient Risk Stratification Market

  • 28.1. Middle East Patient Risk Stratification Market Overview
  • 28.2. Middle East Patient Risk Stratification Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Patient Risk Stratification Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Patient Risk Stratification Market, Segmentation By Delivery Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Patient Risk Stratification Market

  • 29.1. Africa Patient Risk Stratification Market Overview
  • 29.2. Africa Patient Risk Stratification Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Patient Risk Stratification Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Patient Risk Stratification Market, Segmentation By Delivery Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Patient Risk Stratification Market Competitive Landscape And Company Profiles

  • 30.1. Patient Risk Stratification Market Competitive Landscape
  • 30.2. Patient Risk Stratification Market Company Profiles
    • 30.2.1. Bristol-Myers Squibb Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Sales Force Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis

31. Patient Risk Stratification Market Other Major And Innovative Companies

  • 31.1. Siemens Healthineers AG
  • 31.2. Koninklijke Philips N.V.
  • 31.3. GE HealthCare Technologies Inc.
  • 31.4. Adobe Inc.
  • 31.5. Persistent Systems
  • 31.6. NextGen Healthcare Inc.
  • 31.7. Health Catalyst
  • 31.8. Freenome
  • 31.9. Strive Health
  • 31.10. Medeanalytics Inc.
  • 31.11. American Academy of Family Physicians
  • 31.12. Lightbeam Health Solutions
  • 31.13. Graphnet Health Ltd.
  • 31.14. Innova Medical Group Inc.
  • 31.15. Equipo Health Inc.

32. Global Patient Risk Stratification Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Patient Risk Stratification Market

34. Recent Developments In The Patient Risk Stratification Market

35. Patient Risk Stratification Market High Potential Countries, Segments and Strategies

  • 35.1 Patient Risk Stratification Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Patient Risk Stratification Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Patient Risk Stratification Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer